Vasculitis – Non-ANCA-Associated & Related Disorders Poster I
Friday, November 6, 2020
9:00 AM – 11:00 AM ET
Poster session.
Presentations:
9:00 AM – 11:00 AM ET
Comparison of Immediate Post-Operative and Long-Term Outcomes in Aortitis and Non-Inflammatory Thoracic Aortic Aneurysms Undergoing Open Surgical Repair Adam S. Mayer, MD – University of Pennsylvania
9:00 AM – 11:00 AM ET
Isolated Aortitis: Single Centre Experience of Clinical Spectrum and Management Nadia Ahmad, MRCP – Oxford University Hospital
9:00 AM – 11:00 AM ET
Disease Activity and Quality-of-Life Outcomes in Patients with Behçet’s Syndrome Who Achieved and Maintained Oral Ulcer Complete Response with Apremilast Treatment Gülen Hatemi – Istanbul University Cerrahpasa Medical Faculty
9:00 AM – 11:00 AM ET
Infliximab in Refractory Uveitis Due to Behçet’s Disease: Long Term Follow-up and Therapy Optimization. Multicenter Study of 103 Caucasian Patients Jose Luis Martín-Varillas, MD – Hospital Sierrallana
9:00 AM – 11:00 AM ET
Achievement of Early and Sustained Complete Response of Oral Ulcers with Apremilast Compared with Placebo in Patients with Active Behçet’s Syndrome Gülen Hatemi – Istanbul University Cerrahpasa Medical Faculty
9:00 AM – 11:00 AM ET
Epidemiology and Treatment of Behçet’s Disease Insights from the Rheumatology Informatics System for Effectiveness (RISE) Registry Nevin Hammam, MD, PhD – Department of Medicine, University of California, San Francisco VA Medical Center
9:00 AM – 11:00 AM ET
Clinical Characteristics, Brain MRI Findings, and Diagnostic Approach of the Central Nervous System Vasculitis by Affected Vessel Size Rula A. Hajj-ali, MD – Cleveland Clinic
9:00 AM – 11:00 AM ET
WITHDRAWN
9:00 AM – 11:00 AM ET
Serial Vessel Wall Enhancement Change on High-Resolution MRI Vessel Wall Imaging in Primary Central Nervous System Vasculitis Rula A. Hajj-ali, MD – Cleveland Clinic
9:00 AM – 11:00 AM ET
WITHDRAWN
9:00 AM – 11:00 AM ET
Coronavirus Infection and Vasculitis: Identifying Associations Mining the Biomedical Literature Alicia Rodriguez Pla, MD, PhD, RhMSUS, MPH – Mayo Clinic in Arizona
9:00 AM – 11:00 AM ET
Clinical Characteristics of an Internet-Based Cohort of Participants with a Self-Reported Diagnosis of Cryoglobulinemic Vasculitis or IgA Vasculitis Jason Springer, MD, MS – Vanderbilt University Medical Center
9:00 AM – 11:00 AM ET
Characteristics of Arthritis in Adult IgA Vasculitis Alojzija Hocevar, MD – University Medical Center Ljubljana
9:00 AM – 11:00 AM ET
IgG4-related Retroperitoneal Fibrosis. Retrospective Cohort Ernestina Angarola, MD – Hospital Italiano de Buenos Aires
9:00 AM – 11:00 AM ET
Different Immunophenotypes Characterized IgG4-Related Disease Clinical Phenotypes Eduardo Martin-Nares, MD, MSc – Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
9:00 AM – 11:00 AM ET
Prevalence of Thyroid Disease Among Patients with Vasculitis Tanaz Kermani, MD – University of California Los Angeles
9:00 AM – 11:00 AM ET
Survival and Prevalent Comorbidities in Polymyalgia Rheumatica Carl Turesson, MD – Lund University
9:00 AM – 11:00 AM ET
Prospective Analysis of the Prevalence of Giant Cell Arteritis in Consecutive Newly Diagnosed Patients with Polymyalgia Rheumatica Valentin S. Schäfer, MD, PhD – University Hospital Bonn
9:00 AM – 11:00 AM ET
Polymyalgia Rheumatica Is Associated with Later Menopause: An Observational Study Sarah Dyball, MBBS – University of Manchester
9:00 AM – 11:00 AM ET
Frailty and Health-Related Quality of Life in Patients with Polymyalgia Rheumatica Sebastian E. Sattui, MD, MS – Hospital for Special Surgery
9:00 AM – 11:00 AM ET
Defining Ear Chondritis: Data from 685 Patients with Relapsing Polychondritis Marcela Ferrada, MD – National Institutes of Health
9:00 AM – 11:00 AM ET
Anti-Collagen II Antibodies in Patients with Relapsing Polychondritis Kristina Wells, BS – National Institutes of Health
9:00 AM – 11:00 AM ET
MAGIC Syndrome in a Cohort of Patients with Relapsing Polychondritis Yiming Luo, MD – National Institutes of Health
9:00 AM – 11:00 AM ET
T-Cell Receptor (TCR) Sequencing Reveals Decreased Diversity and Clonotypic Expansion of T-cells in Relapsing Polychondritis (RP) Emily B. Rominger, BA – National Institutes of Health
9:00 AM – 11:00 AM ET
Validation of Physician Global Assessment as an Outcome Measure in Relapsing Polychondritis Emily Rose, BS – Systemic Autoimmunity Branch, Vasculitis Translational Research Program, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health
9:00 AM – 11:00 AM ET
Enrichment of Clinical Trial Recruitment Using Advanced Molecular Imaging in Takayasu’s Arteritis Kaitlin A. Quinn, MD – National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH)
